The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer

Surgery

Volumn 143, Issue 5, 2008, Pages 658-666

  Smith, Richard A ^a   Bosonnet, Lorraine ^a   Ghaneh, Paula ^a   Sutton, Robert ^a   Evans, Johnathan ^b   Healey, Priya ^b   Garvey, Connall ^b   Hughes, Mark ^b   Raraty, Michael ^a   Campbell, Fiona ^b   Neoptolemos, John P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER INVASION; CANCER PATIENT; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LAPAROSCOPY; LAPAROTOMY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE DATABASE; RISK ASSESSMENT; SURGICAL RISK; THROMBOCYTE COUNT; VATER PAPILLA CARCINOMA;

AGED; CA-19-9 ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; LAPAROSCOPY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PATIENT SELECTION; PLATELET COUNT;

EID: 43049141078     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.12.014     Document Type: Article

References (41)

1. Alexakis N., Halloran C., Raraty M., et al. Current standards of surgery for pancreatic cancer. Br J Surg 91 (2004) 1410-1427
2. Bipat S., Phoa S.S., van Delden O.M., et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 29 (2005) 438-445
3. House M.G., Yeo C.J., Cameron J.L., et al. Predicting resectability of periampullary cancer with three-dimensional computed tomography. J Gastrointest Surg 8 (2004) 280-288
4. Midwinter M.J., Beveridge C.J., Wilsdon J.B., et al. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 86 (1999) 189-193
5. Doran H.E., Bosonnet L., Connor S., et al. Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours. Dig Surg 21 (2004) 305-313
6. Vollmer C.M., Drebin J.A., Middleton W.D., et al. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg 235 (2002) 1-7
7. Taylor A.M., Roberts S.A., and Manson J.M. Experience with laparoscopic ultrasonography for defining tumour resectability in carcinoma of the pancreatic head and peri-ampullary region. Br J Surg 88 (2001) 1077-1083
8. Kim H.J., Kim M.H., Myung S.J., et al. A new strategy for the application of CA19-9 in the differentiation of pancreato-biliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol 94 (1999) 1941-1946
9. Brockmann J., Emparan C., Hernandez C.A., et al. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies. Anticancer Res 20 (2000) 4941-4947
10. Connor S., Bosonnet L., Alexakis N., et al. Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy. Dig Surg 22 (2005) 80-85
11. Karachristos A., Scarmeas N., and Hoffman J.P. CA19-9 levels predict results of staging laparoscopy in pancreatic cancer. J Gastrointest Surg 9 (2005) 1286-1292
12. Schlieman M.G., Ho H.S., and Bold R.J. Utility of tumour markers in determining resectability of pancreatic cancer. Arch Surg 138 (2003) 951-956
13. Halloran C.M., Ghaneh P., Connor S., et al. CA19-9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy. Br J Surg 95 (2007) 453-459
14. Jamieson N.B., Glen P., McMillan D.C., et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma of the head of pancreas. Br J Cancer 92 (2005) 21-23
15. Suzuki K., Aiura K., Kitagou M., et al. Platelet counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology 51 (2004) 847-853
16. Brown K.M., Domin C., Aranha G.V., et al. Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. Am J Surg 189 (2005) 278-282
17. Yamaguchi K., Noshiro H., Shimizu S., et al. Long-term and short-term survivors after pancreatectomy for pancreatic cancer. Int Surg 85 (2000) 71-76
18. Fogar P., Sperti C., Basso D., et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 32 (2006) 22-28
19. Campbell F., Bennett M., and Foulis A.J. Minimum dataset for histopathological reporting of pancreatic, ampulla of Vater and bile duct carcinoma. The Royal College of Pathologists Web site (2002). Available http://www.rcpath.org/index.asp?pageId=1163 Accessed 02/01/2008
20. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
21. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. 5th ed. (1997), Wiley-Liss, New York
22. Minnard E.A., Conlon K.C., Hoos A., et al. Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. Ann Surg 228 (1998) 182-187
23. Nieveen van Dijkum E.J., Romijn M.G., Terwee C.B., et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 237 (2003) 66-73
24. Doucas H., Sutton C.D., Zimmerman A., et al. Assessment of pancreatic malignancy with laparoscopy and intraoperative ultrasound. Surg Endosc 21 (2007) 1147-1152
25. Ellsmere J., Moltele K., Sahari D., et al. Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing the resectability of pancreatic head adenocarcinoma?. Surg Endosc 19 (2005) 369-373
26. Thomson B.N., Parks R.W., Redhead D.N., et al. Refining the role of laparoscopy and laparoscopic ultrasound in the staging of presumed pancreatic head and ampullary tumours. Br J Cancer 94 (2006) 213-217
27. Dewitt J., Devereaux B.M., Lehman G.A., et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 4 (2006) 717-725
28. Brooks A.D., Mallis M.J., Brennan M.F., et al. The value of laparoscopy in the management of ampullary, duodenal and distal bile duct tumours. J Gastrointest Surg 6 (2002) 139-146
29. Suzuki O., Shichinohe T., Yano T., et al. Laparoscopic modified Devine exclusion gastrojejunostomy as a palliative surgery to relieve malignant pyloroduodenal obstruction by unresectable cancer. Am J Surg 194 (2007) 416-418
30. Kazanjian K.K., Reber H.A., and Hines O.J. Laparoscopic gastrojejunostomy for gastric outlet obstruction in pancreatic cancer. Am Surg 70 (2004) 910-913
31. Kloppel G., Solcia E., Longnecker D.S., et al. Histological typing of tumours of the exocrine pancreas, 2nd ed. WHO international histological classification of tumours (1996), Springer-Verlag, Berlin
32. Salazar-Onfray F., Lopez M.N., and Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor escape. Cytokine Growth Factor Rev 18 (2007) 171-182
33. Bellone G., Turletti A., Artusio E., et al. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol 155 (1999) 537-547
34. Romano F., Uggeri F., Crippa S., et al. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers. J Exp Clin Cancer Res 23 (2004) 195-200
35. Klinger M.H., and Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22 (2002) 913-922
36. Alexandrakis M.G., Passam F.H., Moschandrea I.A., et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol 26 (2003) 135-140
37. Monreal M., Fernandez-Llamazares J., Pinol M., et al. Platelet count and survival in colorectal cancer-a preliminary study. Thromb Haemost 79 (1998) 916-918
38. Ikeda M., Furukawa H., Imamura H., et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9 (2002) 287-291
39. Shimada H., Oohira G., Okazumi S., et al. Thrombocytosis associated with poor prognosis in patients with oesophageal carcinoma. J Am Coll Surg 198 (2004) 737-741
40. Itzjowitz S., and Kim Y. New carbohydrate tumour markers. Gastroenterology 90 (1986) 491-494
41. Jagannath P., Dhir V., Shrikhande S., et al. Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy. Br J Surg 92 (2005) 356-361